Literature DB >> 16842243

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.

L G Fulford1, D F Easton, J S Reis-Filho, A Sofronis, C E Gillett, S R Lakhani, A Hanby.   

Abstract

AIMS: Cytokeratin (CK) 14, a myoepithelial marker, is also expressed in a proportion of breast carcinomas. There is evidence that these tumours show a differing metastatic pattern and clinical outcome from other invasive ductal carcinomas (IDCs) and may need different management. Currently, they are not identified in routine practice and no morphological guidelines exist to aid their identification. The aim of this study was to analyse the histological features of CK14+ IDC. METHODS AND
RESULTS: A detailed histological review of 453 grade 3 IDCs revealed 88 (19.4%) that expressed CK14. Assessment was made independently by two pathologists using a standardized 'tick-box' proforma covering grade, architectural and cytological features. The results were analysed using logistic regression to identify features that predicted for basal phenotype. Concordance between the two pathologists was fair to good for most parameters (kappa 0.4-0.6). On multiple logistic regression, the basal phenotype was highly significantly associated with the presence of a central scar (P = 0.005), tumour necrosis (P < 0.0001), presence of spindle cells (P = 0.006) or squamous metaplasia (P < 0.0001), high total mitotic count (> 40 per 10 high-power field) (P = 0.0002) and high nuclear-cytoplasmic ratio (P = 0.0002).
CONCLUSIONS: Specific morphological features are strongly associated with basal-like breast carcinoma. These could be used in routine diagnostic practice to identify this important subset of tumours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842243     DOI: 10.1111/j.1365-2559.2006.02453.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  93 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

Review 2.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

Review 3.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

4.  TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.

Authors:  Gianluca Storci; Pasquale Sansone; Sara Mari; Gabriele D'Uva; Simona Tavolari; Tiziana Guarnieri; Mario Taffurelli; Claudio Ceccarelli; Donatella Santini; Pasquale Chieco; Kenneth B Marcu; Massimiliano Bonafè
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

5.  Bcl-2 expression and triple negative profile in breast carcinoma.

Authors:  Imen Kallel-Bayoudh; Hanen Ben Hassen; Abdelmajid Khabir; Noureddine Boujelbene; Jamel Daoud; Mounir Frikha; Tahia Sallemi-Boudawara; Sami Aifa; Ahmed Rebaï
Journal:  Med Oncol       Date:  2010-10-02       Impact factor: 3.064

6.  Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.

Authors:  Kathy A Toy; Rajeshwari R Valiathan; Fernando Núñez; Kelley M Kidwell; Maria E Gonzalez; Rafael Fridman; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2015-02-10       Impact factor: 4.872

7.  Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.

Authors:  Rohit Bhargava; Joan Striebel; Sushil Beriwal; John C Flickinger; Agnieszka Onisko; Gretchen Ahrendt; David J Dabbs
Journal:  Int J Clin Exp Pathol       Date:  2009-02-09

8.  Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

Authors:  Mohammed S Fayaz; Mustafa S El-Sherify; Amany El-Basmy; Sadeq A Zlouf; Nashwa Nazmy; Thomas George; Susan Samir; Gerges Attia; Heba Eissa
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-26

9.  Chromosomal changes in aggressive breast cancers with basal-like features.

Authors:  Wayne Yu; Yasmine Kanaan; Young Kyung Bae; Young-Kyung Baed; Edward Gabrielson
Journal:  Cancer Genet Cytogenet       Date:  2009-08

10.  Prevalence of molecular subtypes of invasive breast cancer: A retrospective study.

Authors:  Nikhilesh Kumar; Preeti Patni; A Agarwal; M A Khan; Nidhi Parashar
Journal:  Med J Armed Forces India       Date:  2015-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.